Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sorrento Therapeutics Inc SRNE

Healthcare Biotechnology
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G... see more

Recent & Breaking News (GREY:SRNE)

SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors With Losses Exceeding $250K to Contact the Firm

ACCESSWIRE IA July 16, 2020

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Actions Against Sorrento Therapeutics, Inc. (SRNE) and July 27 Deadline

GlobeNewswire July 16, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Colony Capital, Sorrento Therapeutics, Carnival Corporation, and Wells Fargo and Encourages Investors to Contact the Firm

GlobeNewswire July 15, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

PR Newswire July 13, 2020

SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors With Losses Exceeding $250K to Contact the Firm

GlobeNewswire July 13, 2020

Thinking about trading options or stock in Sorrento Therapeutics, Netflix, United Airlines, Royal Caribbean Cruises, or Plug Power?

PR Newswire July 13, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

Newsfile July 9, 2020

Shareholder Alert: Robbins LLP Announces It Is Investigating Sorrento Therapeutics, Inc. (SRNE) for Misleading Shareholders

Business Wire July 9, 2020

SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Southern District of California against Sorrento Therapeutics, Inc.

GlobeNewswire July 9, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

ACCESSWIRE IA July 9, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sorrento Therapeutics, Carnival Corporation, Wells Fargo, and Hebron Technology and Encourages Investors to Contact the Firm

GlobeNewswire July 8, 2020

Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm

Newsfile July 8, 2020

SRNE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 27, 2020 in the Class Action Filed on Behalf of Sorrento Therapeutics, Inc. Limited Shareholders

Newsfile July 7, 2020

SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders of Class Action Against and Encourages Investors With Losses Exceeding $250K to Contact the Firm

ACCESSWIRE IA July 7, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

Newsfile July 6, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

GlobeNewswire July 6, 2020

Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm

Newsfile July 3, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

GlobeNewswire July 1, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hamilton Beach Brands, Colony Capital, Sorrento Therapeutics, and Carnival Corporation and Encourages Investors to Contact the Firm

GlobeNewswire July 1, 2020

SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders of Class Action Against and Encourages Investors With Losses Exceeding 250K to Contact the Firm

GlobeNewswire July 1, 2020